Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus

Dermatologic Therapy

Volumn 20, Issue 2, 2007, Pages 93-101

  Albrecht, Joerg ^b   Werth, Victoria P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Jr Hospital of Cook County   (United States)

Author keywords

Cutaneous lupus erythematosus; Patient outcome assessment; Reproducibility of results; Validity

Indexed keywords

ALGORITHM; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CLINICAL RESEARCH; DISEASE ACTIVITY; DISEASE SEVERITY; ERYTHEMA; HUMAN; MEASUREMENT; OUTCOME ASSESSMENT; RELIABILITY; REVIEW; SKIN LUPUS ERYTHEMATOSUS; VALIDATION PROCESS; VISUAL ANALOG SCALE;

HEALTH STATUS INDICATORS; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 34249304835     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2007.00117.x     Document Type: Review

References (33)

1. Tebbe B, Orfanos CE. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 1997 : 6 : 96 104.
2. O'Quinn SE, Cole J, Many H. Problems of disability and rehabilitation in patients with chronic skin diseases. Arch Dermatol 1972 : 105 : 35 41.
3. Center for Drug Evaluation Research (CDER). Systemic lupus erythematosus - developing drugs for treatment (Guidance for Industry - Draft) 3/24/2005 http://www.fda.gov/CDER/guidance/6496dft.htm. Accessed March 24, 2007.
4. Parodi A, Massone C, Cacciapuoti M, et al. Measuring the activity of the disease in patients with cutaneous lupus erythematosus. Br J Dermatol 2000 : 142 : 457 460.
5. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992 : 35 : 630 640.
6. Urowitz MB, Gladman DD, Tozman EC, Goldsmith CH. The lupus activity criteria count (LACC). J Rheumatol 1984 : 11 : 783 787.
7. Gladman DD, Urowitz MB, Ong A, Gough J, MacKinnon A. A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE). Lupus 1996 : 5 : 190 195.
8. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989 : 32 : 1107 1118.
9. Charman C, Williams H. Outcome measures of disease severity in atopic eczema. Arch Dermatol 2000 : 136 : 763 769.
10. Available at: http://www.medal.com. Accessed November 26 2006.
11. Faust HB, Gonin R, Chuang TY, Lewis CW, Melfi CA, Farmer ER. Reliability testing of the dermatology index of disease severity (DIDS). An index for staging the severity of cutaneous inflammatory disease. Arch Dermatol 1997 : 133 : 1443 1448.
12. Albrecht J, Werth V. Outcome measures in Cutaneous Autoimmune Diseases: Dermatomyositis and Lupus Erythematosus. In : Sarzi-Puttini P, Doria A, Kuhn A, Girolomoni G, Asherson R, eds. The skin in systemic autoimmune diseases. Amsterdam : Elsevier Science, 2006 : 207 220.
13. Finlay AY. Measurement of disease activity and outcome in atopic dermatitis. Br J Dermatol 1996 : 135 : 509 515.
14. Albrecht J, Taylor L, Berlin JA, et al. The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus. J Invest Dermatol 2005 : 125 : 889 894.
15. Berth-Jones J, Thompson J, Graham-Brown RA. Evening primrose oil and atopic eczema. Lancet 1995 : 345 : 520.
16. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993 : 186 : 23 31.
17. Lahti A, Kopola H, Harila A, Myllyla R, Hannuksela M. Assessment of skin erythema by eye, laser Doppler flowmeter, spectroradiometer, two-channel erythema meter and Minolta chroma meter. Arch Dermatol Res 1993 : 285 : 278 282.
18. Quinn AG, McLelland J, Essex T, Farr PM. Quantification of contact allergic inflammation: a comparison of existing methods with a scanning laser Doppler velocimeter. Acta Derm Venereol 1993 : 73 : 21 25.
19. Bonilla-Martinez Z, Albrecht J, Taylor L, Okawa J, Werth V. The CLASI is a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosus. Arthritis Rheum 2006 : 54 : S434.
20. Charman CR, Venn AJ, Williams HC. Measurement of body surface area involvement in atopic eczema: an impossible task? Br J Dermatol 1999 : 140 : 109 111.
21. Tiling-Grosse S, Rees J. Assessment of area of involvement in skin disease: a study using schematic figure outlines. Br J Dermatol 1993 : 128 : 69 74.
22. Ramsay B, Lawrence CM. Measurement of involved surface area in patients with psoriasis. Br J Dermatol 1991 : 124 : 565 570.
23. Lucky AW, Barber BL, Girman CJ, Williams J, Ratterman J, Waldstreicher J. A multirater validation study to assess the reliability of acne lesion counting. J Am Acad Dermatol 1996 : 35 : 559 565.
24. Vardy D, Besser A, Amir M, Gesthalter B, Biton A, Buskila D. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol 2002 : 147 : 736 742.
25. Williams HC. Is a simple generic index of dermatologic disease severity an attainable goal? Arch Dermatol 1997 : 133 : 1451 1452.
26. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001 : 137 : 280 284.
27. Nichol MB, Margolies JE, Lippa E, Rowe M, Quell J. The application of multiple quality-of-life instruments in individuals with mild-to-moderate psoriasis. Pharmacoeconomics 1996 : 10 : 644 653.
28. Miller SF, Finley RK, Waltman M, Lincks J. Burn size estimate reliability: a study. J Burn Care Rehabil 1991 : 12 : 546 559.
29. Long CC, Mills CM, Finlay AY. A practical guide to topical therapy in children. Br J Dermatol 1998 : 138 : 293 296.
30. Williams H. "Objective" measures of atopic dermatitis severity: in search of the holy grail. Arch Dermatol 2003 : 139 : 1490 1492.
31. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use, 2nd ed. Oxford : Oxford University Press, 1995.
32. Carr AJ, Higginson IJ. Are quality of life measures patient centred? BMJ 2001 : 322 : 1357 1360.
33. Aringer M, Smolen JS. [Systemic lupus erythematosus - activity and outcome.]. Z Rheumatol 2006.